- Home
- IRMD vs PSNL Comparison
IRMD vs PSNL Comparison
Compare IRMD & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IRMD | PSNL |
|---|---|---|
| Founded | 1992 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | IRMD | PSNL |
|---|---|---|
| Price | $87.61 | $17.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $116.00 | $12.20 |
| AVG Volume (30 Days) | 108.2K | ★ 3.5M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | 16.67 | ★ 33.58 |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $83,814,000.00 | $69,648,000.00 |
| Revenue This Year | $12.38 | $15.34 |
| Revenue Next Year | $11.31 | $41.46 |
| P/E Ratio | $101.16 | ★ N/A |
| Revenue Growth | ★ 14.43 | N/A |
| 52 Week Low | $67.84 | $4.67 |
| 52 Week High | $107.90 | $18.89 |
Technical Indicators
Market Signals| Indicator | IRMD | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 41.27 | 63.05 |
| Support Level | $84.05 | $7.36 |
| Resistance Level | $88.72 | $18.89 |
| Average True Range (ATR) | 2.33 | 0.76 |
| MACD | 0.09 | 0.18 |
| Stochastic Oscillator | 32.47 | 59.79 |
Price Performance
Historical ComparisonAbout IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.